Chapel Hill, NC, United States of America

Scott W J McPhee

This inventor holds 2 USPTO granted patents. Top assignees: Bamboo Therapeutics, Inc., The University of North Carolina at Chapel Hill. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott W J McPhee. Retrieved from https://idiyas.com/inventor/scott-w-j-mcphee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Scott W J McPhee: Innovator in Mini-Dystrophin Gene Technology

Introduction

Scott W J McPhee is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of gene therapy, particularly in the development of mini-dystrophin proteins. With a total of two patents to his name, McPhee's work is paving the way for advancements in medical treatments.

Latest Patents

McPhee's latest patents focus on optimized mini-dystrophin genes and expression cassettes. These inventions relate to polynucleotides encoding mini-dystrophin proteins, viral vectors comprising the same, and methods for delivering mini-dystrophin to a cell or a subject. This innovative approach has the potential to improve therapeutic strategies for muscular dystrophies.

Career Highlights

Throughout his career, McPhee has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Bamboo Therapeutics, Inc. His research has been instrumental in advancing the understanding and application of gene therapy techniques.

Collaborations

Some of McPhee's notable coworkers include Xiao Xiao and Juan Li. Their collaborative efforts have contributed to the success of his research and innovations in the field.

Conclusion

Scott W J McPhee is a prominent figure in the realm of gene therapy, particularly known for his work on mini-dystrophin proteins. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…